Correlation Between Eyenovia and Exagen

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Eyenovia and Exagen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eyenovia and Exagen into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eyenovia and Exagen Inc, you can compare the effects of market volatilities on Eyenovia and Exagen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eyenovia with a short position of Exagen. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eyenovia and Exagen.

Diversification Opportunities for Eyenovia and Exagen

-0.84
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Eyenovia and Exagen is -0.84. Overlapping area represents the amount of risk that can be diversified away by holding Eyenovia and Exagen Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Exagen Inc and Eyenovia is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eyenovia are associated (or correlated) with Exagen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Exagen Inc has no effect on the direction of Eyenovia i.e., Eyenovia and Exagen go up and down completely randomly.

Pair Corralation between Eyenovia and Exagen

Given the investment horizon of 90 days Eyenovia is expected to under-perform the Exagen. In addition to that, Eyenovia is 1.86 times more volatile than Exagen Inc. It trades about -0.11 of its total potential returns per unit of risk. Exagen Inc is currently generating about 0.14 per unit of volatility. If you would invest  252.00  in Exagen Inc on October 7, 2024 and sell it today you would earn a total of  106.00  from holding Exagen Inc or generate 42.06% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Eyenovia  vs.  Exagen Inc

 Performance 
       Timeline  
Eyenovia 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Eyenovia has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in February 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
Exagen Inc 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Exagen Inc are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of very weak technical and fundamental indicators, Exagen displayed solid returns over the last few months and may actually be approaching a breakup point.

Eyenovia and Exagen Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Eyenovia and Exagen

The main advantage of trading using opposite Eyenovia and Exagen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eyenovia position performs unexpectedly, Exagen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Exagen will offset losses from the drop in Exagen's long position.
The idea behind Eyenovia and Exagen Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

Other Complementary Tools

Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Commodity Directory
Find actively traded commodities issued by global exchanges
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios